Synapse

← Current Drug Targets - Immune Endocrine & Metabolic Disorders

Papers in Current Drug Targets - Immune Endocrine & Metabolic Disorders

Page 2 · newest first

  1. Studies on Human Neutrophil Biological Functions by Means of Formylpeptide Receptor Agonists and AntagonistsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2003
  2. Unfolding the Pathophysiological Role of Bioactive LysophospholipidsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2003
  3. Controlled Modulation of Inflammatory, Stress and Apoptotic Responses in MacrophagesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2003
  4. Vaccination Against Leishmania InfectionsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  5. Molecular and Cellular Tools in Human Cystic EchinococcosisCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  6. Prospects for A Human Toxoplasma VaccineCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  7. Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 DiabetesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  8. Apoptotic Cell Death in Renal Injury: The Rationale for InterventionCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  9. Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic β Cell Function: Potential Therapeutic ImplicationsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  10. Common Treatment of Polycystic Ovarian Syndrome and Major Depressive Disorder: Case Report and ReviewCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  11. Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based TherapyCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  12. Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based TherapyCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
  13. Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin ResistanceCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  14. A New Molecular Target of Insulin Action: Regulating the Pivotal PDK1Current Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  15. Immune Responses to Fungal Infections and Therapeutic ImplicationsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  16. Cytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  17. Molecular Basis for Designing Selective Modulators of Retinoic Acid Receptor Transcriptional ActivitiesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  18. Mechanisms of Interferon Mediated Anti-Viral ResistanceCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  19. Metastatic Thyroid Cancer Unresponsive to Conventional Therapies: Novel Management Approaches Through Translational Clinical ResearchCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  20. Estrogens and Colorectal CancerCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  21. Treatment of Rheumatoid Arthritis New Therapeutic Approaches with Biological AgentsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  22. Plasmid DNA VaccinesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
  23. Advances in the Treatment of OsteoporosisCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001